Bioreactor platform for point-of-care autologous, clinical-grade stem cell manufacturing that enables clinical-scale 3D cultivation of adherent cells such as MSCs. Closed, automated, closed system compatible with upstream/downstream workflows, offering a cost-effective alternative to 2D culture and up to 2000× expansion in a single passage.